Results 211 to 220 of about 104,207 (331)

PYRIMIDINE NUCLEOSIDE ANTAGONISTS [PDF]

open access: yesJournal of Biological Chemistry, 1951
Donald W. Visser, T. Kay Fukuhara
openaire   +2 more sources

A Pseudo‐catalytic Network Motif for Thiol‐based Chemical Reaction Networks

open access: yesChemSystemsChem, Volume 7, Issue 2, March 2025.
The synthesis of chemical reaction networks (CRNs) is a challenging task. Herein, we designed a pseudo‐catalytic network motif for thiol‐based CRNs. This motif involves the reaction between organic thiocyanates and cystamine. Due to the nucleophilic chain mechanism, the rate of this reaction is proportional to the concentration of thiols in the system.
Ekaterina A. Zhigileva   +2 more
wiley   +1 more source

The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5. [PDF]

open access: yesSci Adv
Zhao M   +13 more
europepmc   +1 more source

Upregulation of ST3GAL5 predicts suppression of malignant biological behavior in bladder cancer

open access: yesUroPrecision, EarlyView.
Abstract Background Bladder cancer (BLCA) is the most prevalent malignancy in the urinary tract system, while ST3GAL5 is a protein‐coding gene that catalyzes the formation of ganglioside monosialodihexosylganglioside 3 (GM3) synthase. GM3 synthase has been reported to significantly influence the malignant process of various cancers.
Song Ou‐Yang   +3 more
wiley   +1 more source

Nanotechnology and cell death: Revolutionizing disease treatment with nanoparticle strategies

open access: yesVIEW, EarlyView.
Traditional disease treatments often face issues such as poor drug targeting and significant side effects, with many complex diseases lacking effective therapies. Our research utilizes tiny nanomaterials to treat diseases by regulating natural cell death processes, improving the immune environment, etc., enabling drugs to act more precisely.
Yiwen Wan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy